Published in

Elsevier, Journal of Hepatology, 1(78), p. 142-152, 2023

DOI: 10.1016/j.jhep.2022.09.014

Links

Tools

Export citation

Search in Google Scholar

LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma

Journal article published in 2022 by Caitlin B. Conboy ORCID, Jennifer A. Yonkus, EeeLN H. Buckarma, Dong-Gi Mun, Nathan W. Werneburg, Ryan D. Watkins ORCID, Roberto Alva-Ruiz ORCID, Jennifer L. Tomlinson, Yi Guo, Juan Wang, Daniel O’Brien, Chantal E. McCabe ORCID, Erik Jessen, Rondell P. Graham ORCID, Rogier C. Buijsman ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO